BAJAJ BROKING

Notification close image
No new Notification messages
card image
Knowledge Realty Trust IPO is Open!
Apply for the Knowledge Realty Trust IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

28314

506260

ANUHPHR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ANUH PHARMA LIMITED performance

Today’s low

Today’s high

₹ 93.67 ₹ 95.79
₹ 95.03

52 week low

52 week high

₹ 74.25 ₹ 122.85
₹ 95.03

Open Price

₹ 93.67

Prev. Close

₹ 93.66

Volume (Shares)

5286.00

Total traded value

₹ 5.02

Upper Circuit

₹ 112.39

Lower Circuit

₹ 74.92

info

ANUH PHARMA LIMITED Share Price Update

As of the latest trading session, ANUH PHARMA LIMITED share price is currently at ₹ 95.05, which is up by ₹ 1.38 from its previous closing. Today, the stock has fluctuated between ₹ 93.67 and ₹ 95.79. Over the past year, ANUH PHARMA LIMITED has achieved a return of -15.94 %. In the last month alone, the return has been -13.08 %. Read More...

Investment Returns

Over 1 Month -13.08% Over 3 Months 10.20% Over 6 Months -5.38% Over 1 Year -15.94%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ANUH PHARMA LIMITED fundamentals


  • Market cap (Cr)

    952.40

  • P/E Ratio (TTM)

    19.85

  • Beta

    0.92

  • Book Value / share

    32.52

  • Return on equity

    13.41%

  • EPS (TTM)

    4.13

  • Dividend yield

    0.80%

  • Net profit/quarter (Cr)

    12.46

info icon alternate text
  • Market cap (Cr)

    962.20

  • P/E Ratio (TTM)

    19.85

  • Beta

    0.76

  • Book Value / share

    32.52

  • Return on equity

    13.41%

  • EPS (TTM)

    4.13

  • Dividend yield

    0.80%

  • Net profit/quarter (Cr)

    12.46

info icon alternate text

ANUH PHARMA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 198.14
Operating Expense 182.25
Net Profit 12.46
Net Profit Margin (%) 6.28
Earnings Per Share (EPS) 2.49
EBITDA 20.07
Effective Tax Rate (%) 27.89
Particulars DEC 2024 (Values in Cr)
Revenue 159.51
Operating Expense 147.19
Net Profit 10.34
Net Profit Margin (%) 6.48
Earnings Per Share (EPS) 2.06
EBITDA 15.72
Effective Tax Rate (%) 22.00
Particulars SEP 2024 (Values in Cr)
Revenue 165.95
Operating Expense 151.16
Net Profit 15.04
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 3.00
EBITDA 20.27
Effective Tax Rate (%) 17.31
Particulars JUN 2024 (Values in Cr)
Revenue 137.91
Operating Expense 129.35
Net Profit 9.51
Net Profit Margin (%) 6.89
Earnings Per Share (EPS) 1.90
EBITDA 14.29
Effective Tax Rate (%) 22.49
Particulars MAR 2024 (Values in Cr)
Revenue 163.89
Operating Expense 146.98
Net Profit 15.36
Net Profit Margin (%) 9.37
Earnings Per Share (EPS) 3.06
EBITDA 22.05
Effective Tax Rate (%) 22.10
Particulars MAR 2025 (Values in Cr)
Revenue 661.51
Operating Expense 609.97
Net Profit 47.35
Net Profit Margin (%) 7.15
Earnings Per Share (EPS) 9.45
EBITDA 70.36
Effective Tax Rate (%) 22.37
Particulars MAR 2024 (Values in Cr)
Revenue 647.00
Operating Expense 580.79
Net Profit 60.06
Net Profit Margin (%) 9.28
Earnings Per Share (EPS) 11.98
EBITDA 87.24
Effective Tax Rate (%) 23.30
Particulars MAR 2023 (Values in Cr)
Revenue 527.49
Operating Expense 486.13
Net Profit 36.18
Net Profit Margin (%) 6.85
Earnings Per Share (EPS) 7.22
EBITDA 57.39
Effective Tax Rate (%) 23.78
Particulars MAR 2022 (Values in Cr)
Revenue 486.65
Operating Expense 452.71
Net Profit 30.56
Net Profit Margin (%) 6.27
Earnings Per Share (EPS) 6.10
EBITDA 52.04
Effective Tax Rate (%) 21.88
Particulars MAR 2021 (Values in Cr)
Revenue 431.96
Operating Expense 403.94
Net Profit 28.44
Net Profit Margin (%) 6.58
Earnings Per Share (EPS) 5.67
EBITDA 55.12
Effective Tax Rate (%) 26.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 65.06
ROE % 13.41
ROCE % 17.15
Total Debt to Total Equity 0.02
EBITDA Margin 9.54
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.11
ROE % 19.49
ROCE % 25.44
Total Debt to Total Equity 0.01
EBITDA Margin 11.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 48.14
ROE % 15.90
ROCE % 20.82
Total Debt to Total Equity 0.01
EBITDA Margin 10.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.66
ROE % 15.11
ROCE % 19.14
Total Debt to Total Equity 0.04
EBITDA Margin 10.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.04
ROE % 12.75
ROCE % 15.72
Total Debt to Total Equity 0.17
EBITDA Margin 11.03
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 19.73
Total Assets 506.62
Total Liabilities 506.62
Total Equity 326.02
Share Outstanding 50112000
Price to Book Ratio 2.29
Return on Assets (%) 9.34
Return on Capital (%) 14.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.37
Total Assets 445.68
Total Liabilities 445.68
Total Equity 291.21
Share Outstanding 50112000
Price to Book Ratio 4.23
Return on Assets (%) 13.47
Return on Capital (%) 20.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 404.98
Total Liabilities 404.98
Total Equity 241.22
Share Outstanding 50112000
Price to Book Ratio 1.65
Return on Assets (%) 8.93
Return on Capital (%) 15
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.94
Total Assets 347.17
Total Liabilities 347.17
Total Equity 213.77
Share Outstanding 50112000
Price to Book Ratio 2.01
Return on Assets (%) 8.80
Return on Capital (%) 14.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 20.09
Total Assets 332.63
Total Liabilities 332.63
Total Equity 190.64
Share Outstanding 50112000
Price to Book Ratio 2.37
Return on Assets (%) 8.54
Return on Capital (%) 13.92
Particulars MAR 2025 (Values in Cr)
Net Income 61.00
Cash from Operations 48.24
Cash from Investing -19.90
Cash from Financing -4.85
Net change in Cash 12.35
Free Cash Flow 68.39
Particulars MAR 2024 (Values in Cr)
Net Income 78.30
Cash from Operations 31.99
Cash from Investing 0.91
Cash from Financing -8.56
Net change in Cash 5.27
Free Cash Flow 37.01
Particulars MAR 2023 (Values in Cr)
Net Income 47.47
Cash from Operations 67.36
Cash from Investing -43.48
Cash from Financing -12.28
Net change in Cash -1.86
Free Cash Flow 68.91
Particulars MAR 2022 (Values in Cr)
Net Income 39.12
Cash from Operations 38.00
Cash from Investing -7.81
Cash from Financing -19.44
Net change in Cash 1.59
Free Cash Flow 39.61
Particulars MAR 2021 (Values in Cr)
Net Income 38.55
Cash from Operations -9.00
Cash from Investing 52.20
Cash from Financing -33.11
Net change in Cash 0.35
Free Cash Flow -2.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.57 28.82 1.78 249.59 31.62 / 69.75
BLISS GVS PHARMA LTD 179.85 17.79 1.80 1897.37 105.05 / 190.65
CIPLA LTD 1515.45 22.70 3.92 122410.66 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 356.10 12.93 2.88 1048.04 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2865.25 51.26 24.87 48539.06 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.57 83.51 5.14 249.59 31.62 / 69.75
AMRUTAJAN HEALTH LTD 672.90 38.28 5.95 1945.40 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8975.05 128.12 29.12 22437.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 179.85 26.88 1.79 1897.37 105.05 / 190.65

ANUH PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
95.03 1.46 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 96.40
  • 26 Days 100.70
  • 10 Days 98.00
  • 50 Days 100.80
  • 12 Days 98.50
  • 100 Days 99.20
  • 20 Days 100.00
  • 200 Days 95.60
94.14 PIVOT

First Support

91.86

First Resistance

95.95

Second Support

90.05

Second Resistance

98.23

Third Support

87.77

Third Resistance

100.04

RSI

35.93

ADX

10.39

MACD

-2.19

Williams % R

-91.41

Commodity Channel Index (CCI)

-138.28

Date

2025-08-04

Week

31940.00

Same Day

45138.00

Month

74854.00

1 Year

0.92

3 Year

0.93

Over 1 Month

-13.08%

down

Over 1 Year

-15.94%

down

Over 3 Months

10.20%

down

Over 3 Years

0.00%

down

Over 6 Months

-5.38%

down

Over 5 Years

0.00%

down

ANUH PHARMA LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
30.05%
Promoter Holdings
69.91%
FII
0.02%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Bharti Bipin Shah 1.94748E7 (19.43%) Shareholding of Promoter and Promoter Group
Prafulla Lalit Shah 1.4499132E7 (14.47%) Shareholding of Promoter and Promoter Group
Bipin Nemchand Shah (huf) 8494200.0 (8.48%) Shareholding of Promoter and Promoter Group
Bipin Nemchand Shah 6221720.0 (6.21%) Shareholding of Promoter and Promoter Group
Bharat Nemchand Shah 3734214.0 (3.73%) Shareholding of Promoter and Promoter Group
Gaurav Satish Shah 3200688.0 (3.19%) Shareholding of Promoter and Promoter Group
Mrudula Jayantilal Shah 2339856.0 (2.33%) Shareholding of Promoter and Promoter Group
Vivek Bipin Shah 2340000.0 (2.33%) Shareholding of Promoter and Promoter Group
Ritesh Bipin Shah 2310808.0 (2.31%) Shareholding of Promoter and Promoter Group
Dina Satish Shah 2220280.0 (2.22%) Shareholding of Promoter and Promoter Group
Samir Jayantilal Shah 1725004.0 (1.72%) Shareholding of Promoter and Promoter Group
Kinjal Siddharth Jhaveri 816160.0 (0.81%) Shareholding of Promoter and Promoter Group
Harshit Bharat Shah 496988.0 (0.5%) Shareholding of Promoter and Promoter Group
Ketan Lalit Shah 479000.0 (0.48%) Shareholding of Promoter and Promoter Group
Praful Kantilal Shah 460664.0 (0.46%) Shareholding of Promoter and Promoter Group
Surekha Bharat Shah 267344.0 (0.27%) Shareholding of Promoter and Promoter Group
Panna Mahesh Shah 200000.0 (0.2%) Shareholding of Promoter and Promoter Group
Japosha Trading Llp 191688.0 (0.19%) Shareholding of Promoter and Promoter Group
Mahesh Kantilal Shah 168010.0 (0.17%) Shareholding of Promoter and Promoter Group
Mrudula Praful Shah 118200.0 (0.12%) Shareholding of Promoter and Promoter Group
Rohan Mahesh Shah 80000.0 (0.08%) Shareholding of Promoter and Promoter Group
Nina Vijay Shah 60000.0 (0.06%) Shareholding of Promoter and Promoter Group
Damyanti N Shah 57132.0 (0.06%) Shareholding of Promoter and Promoter Group
Indu Kishor Mody 28800.0 (0.03%) Shareholding of Promoter and Promoter Group
Kiran Piyush Shah 15388.0 (0.02%) Shareholding of Promoter and Promoter Group
Hemant Babubhai Choksi 24000.0 (0.02%) Shareholding of Promoter and Promoter Group
Madhurika Narendra Shah 12000.0 (0.01%) Shareholding of Promoter and Promoter Group
Aruna Navnit Shah 5040.0 (0.01%) Shareholding of Promoter and Promoter Group
Mukesh Kantilal Shah 14400.0 (0.01%) Shareholding of Promoter and Promoter Group
Urvashi Manoj Sanghavi 14400.0 (0.01%) Shareholding of Promoter and Promoter Group
Neela Pradeep Shah 2800.0 (0.0%) Shareholding of Promoter and Promoter Group
Vikram Kirtilal Shah 200.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ANUH PHARMA LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 1.5 Final 15 Aug 2025 Equity shares
16 Aug 2024 2.5 Final 16 Aug 2024 Equity shares
11 Aug 2023 2.0 Final 11 Aug 2023 Equity shares
03 Aug 2022 1.75 Final 05 Aug 2022 Equity shares
17 Aug 2021 1.5 Final 19 Aug 2021 Equity shares
05 Mar 2020 2.75 Interim 06 Mar 2020 Equity shares
14 Aug 2019 2.75 Final 19 Aug 2019 Equity shares
27 Jul 2018 2.75 Final 31 Jul 2018 Equity shares
15 Sep 2017 2.5 Final 19 Sep 2017 Equity shares
15 Sep 2016 0.5 Final 19 Sep 2016 Equity shares
22 Mar 2016 2.0 Interim 23 Mar 2016 Equity shares
01 Jul 2015 5.0 Final 03 Jul 2015 Equity shares
04 Sep 2014 6.5 Final 08 Sep 2014 Equity shares
04 Sep 2014 2.0 Interim 08 Sep 2014 Equity shares
07 Mar 2014 1.25 Special 10 Mar 2014 Equity shares
25 Jul 2013 6.0 Final 29 Jul 2013 Equity shares
16 Aug 2012 5.5 Final 20 Aug 2012 Equity shares
21 Sep 2011 5.0 Final 23 Sep 2011 Equity shares
22 Feb 2010 10.0 Interim 23 Feb 2010 Equity shares
09 Sep 2009 9.0 Final 11 Sep 2009 Equity shares
09 Sep 2009 2.5 Special 11 Sep 2009 Equity shares
04 Sep 2008 8.0 Final 08 Sep 2008 Equity shares
22 Mar 2007 7.0 Final 23 Mar 2007 Equity shares
21 Sep 2005 0.0 Final 23 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
15 Jul 2025 15 Jul 2025 1:1
21 Sep 2020 18 Sep 2020 1:1
06 Aug 2015 05 Aug 2015 2:1
29 Oct 2010 28 Oct 2010 2:1
07 Aug 2006 31 Jul 2006 1:1
16 Sep 1999 23 Aug 1999 1:1
28 Mar 1995 24 Feb 1995 3:1
Ex-Date Old FV NEW FV Record Date
31 Jul 2006 10.0 5.0 07 Aug 2006
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 1.5 Final 15 Aug 2025 Equity shares
16 Aug 2024 2.5 Final 16 Aug 2024 Equity shares
11 Aug 2023 2.0 Final 11 Aug 2023 Equity shares
03 Aug 2022 1.75 Final 05 Aug 2022 Equity shares
17 Aug 2021 1.5 Final 19 Aug 2021 Equity shares
05 Mar 2020 2.75 Interim 06 Mar 2020 Equity shares
14 Aug 2019 2.75 Final 19 Aug 2019 Equity shares
27 Jul 2018 2.75 Final 31 Jul 2018 Equity shares
15 Sep 2017 2.5 Final 19 Sep 2017 Equity shares
15 Sep 2016 0.5 Final 19 Sep 2016 Equity shares
22 Mar 2016 2.0 Interim 23 Mar 2016 Equity shares
01 Jul 2015 5.0 Final 03 Jul 2015 Equity shares
04 Sep 2014 6.5 Final 08 Sep 2014 Equity shares
04 Sep 2014 2.0 Interim 08 Sep 2014 Equity shares
07 Mar 2014 1.25 Special 10 Mar 2014 Equity shares
25 Jul 2013 6.0 Final 29 Jul 2013 Equity shares
16 Aug 2012 5.5 Final 20 Aug 2012 Equity shares
21 Sep 2011 5.0 Final 23 Sep 2011 Equity shares
22 Feb 2010 10.0 Interim 23 Feb 2010 Equity shares
09 Sep 2009 9.0 Final 11 Sep 2009 Equity shares
09 Sep 2009 2.5 Special 11 Sep 2009 Equity shares
04 Sep 2008 8.0 Final 08 Sep 2008 Equity shares
22 Mar 2007 7.0 Final 23 Mar 2007 Equity shares
21 Sep 2005 0.0 Final 23 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
15 Jul 2025 15 Jul 2025 1:1
21 Sep 2020 18 Sep 2020 1:1
06 Aug 2015 05 Aug 2015 2:1
29 Oct 2010 28 Oct 2010 2:1
07 Aug 2006 31 Jul 2006 1:1
16 Sep 1999 23 Aug 1999 1:1
28 Mar 1995 24 Feb 1995 3:1
Ex-Date Old FV NEW FV Record Date
31 Jul 2006 10.0 5.0 07 Aug 2006

ANUH PHARMA LIMITED Share Price

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals. The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals. It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra.

The Company was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.

The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries.

During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg.

During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production.

In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.

In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.

In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.

The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011.

In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine.

In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It commissioned the new expansion project by starting commercial production in December, 2019.

It received CEP for Ambroxol Hydrochloride from EDQM in 2022. In FY 2023-24, Company has enhanced production capacity from 1,500 MTPAto 1,800 MTPA at Boisar site.

Parent organization Indian Private
NSE symbol ANUHPHR
Founded 1960
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Anuh Pharma Ltd?

Answer Field

Anuh Pharma Ltd share price is for NSE ₹ 95.05 & for BSE ₹ 95.28 as on Aug 05 2025 12:13 PM.

What is the Market Cap of Anuh Pharma Ltd Share?

Answer Field

The market cap of Anuh Pharma Ltd for NSE ₹ 952.40 & for BSE ₹ 0.00 as on Aug 05 2025 12:13 PM.

What is the 52 Week High and Low of Anuh Pharma Ltd?

Answer Field

The 52 Week High and Low of Anuh Pharma Ltd for NSE is ₹ 122.85 and ₹ 74.25 and for BSE is ₹ 124.48 and ₹ 74.03.

What is 1 year return for Anuh Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Anuh Pharma Ltd Share?

Answer Field

As on Aug 05 2025 12:13 PM the price-to-earnings (PE) ratio for Anuh Pharma Ltd share is 19.85.

What is the PB ratio of Anuh Pharma Ltd Share?

Answer Field

As on Aug 05 2025 12:13 PM, the price-to-book (PB) ratio for Anuh Pharma Ltd share is 32.52.

How to Buy Anuh Pharma Ltd Share?

Answer Field

You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anuh Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Anuh Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anuh Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|